Mavenir Selected by Iridium to Deliver Core Network for Global Satellite Based NB-IoT and D2D Services

Strategic partnership to accelerate Iridium NTN Direct services and satellite-terrestrial NB-IoT integration RICHARDSON, Texas, Sept. 23, 2025 (GLOBE NEWSWIRE) — Mavenir, the cloud-native network infrastructure provider building the future of networks, today announced it has been selected by Iridium Communications Inc. (NASDAQ: IRDM), a leading provider of global voice and data satellite communications, to deploy […]

Bitget Becomes First Exchange to Offer All Cryptos on Four Major Chains in One Account

VICTORIA, Seychelles, Sept. 23, 2025 (GLOBE NEWSWIRE) — Bitget, the world’s leading Universal Exchange (UEX), has announced a major upgrade to Bitget Onchain, a revolutionary feature that allows users to seamlessly trade, stake, and manage millions of on-chain tokens directly from a single Bitget spot account. The expansion introduces support for four leading blockchains — […]

Axi Select Celebrates Two Years with $400M+ in Trader Funding and Breakthrough Success Stories

SYDNEY, Sept. 23, 2025 (GLOBE NEWSWIRE) — Axi Select, the pioneering trader development and funding program from global online trading broker Axi, is celebrating its second anniversary with a major milestone — surpassing $400 million in allocated trader funding and cementing its position as the industry’s most innovative prop-style broker-backed program. Since launching in 2023, […]

World Nears Quarter Million Crypto Millionaires in Historic Wealth Boom

LONDON, Sept. 23, 2025 (GLOBE NEWSWIRE) — The ranks of crypto millionaires have surged to an unprecedented 241,700 individuals worldwide, according to the newly released Crypto Wealth Report 2025 by international residence and citizenship advisory specialists Henley & Partners. That’s a remarkable 40% increase in just 12 months, fueled by a dramatic surge in Bitcoin millionaires — up […]

Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset

Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain health diseases, excluding the Republic of Korea, China, Hong Kong, Macau and Taiwan Sovargen receives upfront payment and is eligible for future milestone-dependent payments and royalties Agreement further expands Angelini […]